{
 "name": "愛派司",
 "slug": "tw-6918",
 "aliases": [
  "愛派司生技股份有限公司",
  "A Plus Biotech",
  "6918"
 ],
 "ticker": "6918",
 "industry": "生技醫療業",
 "website": "https://www.aplusbio.com/",
 "summary": "愛派司（6918）是上市的生技醫療類股公司，2009 年成立，2025 年上市。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "愛派司生技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "英文簡稱",
   "value": "A Plus Biotech",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "掛牌市場",
   "value": "臺灣證券交易所上市",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "上市日期",
   "value": "2025-06-10",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "成立日期",
   "value": "2009-09-04",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "董事長",
   "value": "李泗銘",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "總經理",
   "value": "羅翔煒",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "實收資本額",
   "value": 345710000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "公司網址",
   "value": "https://www.aplusbio.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap03_L"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 79515,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原基本資料數值、單位、as_of保留；2026-10-22逐欄核對官方月營收API，與原值（百分比四捨五入至二位）一致。官方出表日期：2026-10-17。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 13.42,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原基本資料數值、單位、as_of保留；2026-10-22逐欄核對官方月營收API，與原值（百分比四捨五入至二位）一致。官方出表日期：2026-10-17。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": 13.44,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://openapi.twse.com.tw/v1/opendata/t187ap05_L",
   "note": "原基本資料數值、單位、as_of保留；2026-10-22逐欄核對官方月營收API，與原值（百分比四捨五入至二位）一致。官方出表日期：2026-10-17。"
  },
  {
   "claim": "管線：APS Osteotomy Fixation System（K252897）",
   "value": "矯正截骨術骨固定｜FDA 510(k)實質等同性通過｜美國",
   "unit": "",
   "as_of": "2025-12-11",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf25/K252897.pdf",
   "note": "FDA決定函日期作文件發布日期；510(k)許可不寫成藥品NDA核准。"
  },
  {
   "claim": "管線：APS Spear Locking Plate（K254053）",
   "value": "小骨骨折及截骨固定｜FDA 510(k)實質等同性通過｜美國",
   "unit": "",
   "as_of": "2026-03-17",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf25/K254053.pdf",
   "note": "FDA決定函日期作文件發布日期；510(k)許可不寫成藥品NDA核准。"
  },
  {
   "claim": "管線：APS Metal Plate & Screw System（K223150）",
   "value": "骨折及截骨固定｜FDA 510(k)實質等同性通過｜美國",
   "unit": "",
   "as_of": "2023-08-24",
   "source": "https://www.accessdata.fda.gov/cdrh_docs/pdf22/K223150.pdf",
   "note": "FDA決定函日期作文件發布日期；510(k)許可不寫成藥品NDA核准。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6918.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}